Large pharmaceutical companies sharing their cash flow with investors through dividends makes a lot of sense. Honestly, there isn't much reason to own Eli Lilly (NYSE: LLY ) , GlaxoSmithKline (NYSE: GSK), and AstraZeneca (NYSE: AZN) except for their oversized dividends. But smaller specialty pharma issuing dividends? I really don't get it.
Earlier this year Questcor Pharmaceuticals (NASDAQ: QCOR ) initiated a quarterly dividend that it's handing out a little early. And this week Spectrum Pharmaceuticals (NASDAQ: SPPI ) said it's issuing a $0.15-per-share special dividend. Really, guys? You can't find any better use for the cash?
Source: Motley Fool
Related Articles:
- Why Dividends Matter
- 6 Dividend Stocks For The New Year
- Bonds Look Morbid When Compared To These Dividend Stocks
- The 2012 Dividend Aristocrats
- Best Stocks for 2012
________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.